Aisling O'Sullivan

Associate Director Global AP & Finance Project Management at PTC Therapeutics

Aisling O'Sullivan has extensive work experience in various roles within the pharmaceutical and technology industries. Aisling currently holds the position of Associate Director Global AP & Finance Project Management at PTC Therapeutics, Inc., where they are responsible for managing projects related to finance and accounts payable on a global scale. Prior to this, they worked at Parexel as a Senior Manager in Clinical Operations, overseeing a team and ensuring the successful execution of clinical studies. Aisling also held roles as a Global Study Start-Up Portfolio Lead, Senior Study Start-Up Critical Path Manager, and Manager Portfolio Payments at Parexel, where they were responsible for strategic planning, risk management, and stakeholder management. Before joining Parexel, they worked at Juniper Networks in credit and collections roles, managing teams and achieving company targets. Aisling also worked as a Credit Controller, Fixed Asset Controller, and Accounts Assistant at Arvato Digital Services, where they handled cash collections and reconciliations. Overall, Aisling O'Sullivan has a proven track record of successfully managing projects, teams, and operational activities in the pharmaceutical and technology sectors.

Aisling O'Sullivan completed their bachelor's degree in Communications at Dublin City University from 1993 to 1997. In 2008, they obtained a certification as a Certified International Credit Professional (CICP) from FCIB. Recently, in 2022, they pursued a short-term course in Change Management at University College Dublin. Aisling has also obtained additional certifications in areas like having difficult conversations, spot coaching, leading change, and essential skills in management.

Links

Previous companies

Parexel logo
Juniper Networks logo

Timeline

  • Associate Director Global AP & Finance Project Management

    September, 2023 - present

  • Senior Manager Global Finance Project Management

    September, 2022

View in org chart